Publications (co-)authored by Kelsey Schafer while in the Biophysics program

[1] 

Kristen E Funk, Stefani N Thomas, Kelsey N Schafer, Grace L Cooper, Zhongping Liao, David J Clark, Austin J Yang, and Jeff Kuret
"Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity."
Biochem. J. 462, 77-88 (2014).

[2] 

Kelsey N Schafer, Katryna Cisek, Carol J Huseby, Edward Chang, and Jeff Kuret
"Structural determinants of tau aggregation inhibitor potency."
J. Biol. Chem. 288, 32599-611 (2013).

[3] 

Kelsey N Schafer, Sohee Kim, Anastasios Matzavinos, and Jeff Kuret
"Selectivity requirements for diagnostic imaging of neurofibrillary lesions in Alzheimers disease: a simulation study."
Neuroimage 60, 1724-33 (2012).

[4] 

Katryna Cisek, Jordan R Jensen, Nicolette S Honson, Kelsey N Schafer, Grace L Cooper, and Jeff Kuret
"Ligand electronic properties modulate tau filament binding site density."
Biophys. Chem. 170, 25-33 (2012).

[5] 

Kelsey N Schafer, Dhiraj P Murale, Kibong Kim, Katryna Cisek, Jeff Kuret, and David G Churchill
"Structure-activity relationship of cyclic thiacarbocyanine tau aggregation inhibitors."
Bioorg. Med. Chem. Lett. 21, 3273-6 (2011).

[6] 

Edward Chang, Sohee Kim, Kelsey N Schafer, and Jeff Kuret
"Pseudophosphorylation of tau protein directly modulates its aggregation kinetics."
Biochim. Biophys. Acta 1814, 388-95 (2011).

[7] 

Jordan R Jensen, Katryna Cisek, Kristen E Funk, Swati Naphade, Kelsey N Schafer, and Jeff Kuret
"Research towards tau imaging."
J. Alzheimers Dis. 26, 147-57 (2011).

[8] 

S Kim, J R Jensen, K Cisek, K E Funk, S Naphade, K Schafer, and J Kuret
"Imaging as a strategy for premortem diagnosis and staging of tauopathies."
Curr Alzheimer Res 7, 230-4 (2010).